[1] ZHU Z X, WANG G Q, YANG F, et al. Foot-and-mouth disease virus viroporin 2B antagonizes RIG-I-mediated antiviral effects by inhibition of its protein expression[J]. J Virol, 2016, 90(24):11106-11121.
[2] MA X Q, LI P H, SUN P, et al. Construction and characterization of 3A-epitope-tagged foot-and-mouth disease virus[J]. Infect Genet Evol, 2015, 31:17-24.
[3] NAYAK A, GOODFELLOW I G, BELSHAM G J. Factors required for the uridylylation of the foot-and-mouth disease virus 3B1, 3B2, and 3B3 peptides by the RNA-dependent RNA polymerase (3D(pol)) in vitro[J]. J Virol, 2005, 79(12):7698-7706.
[4] LI D, YANG W P, YANG F, et al. The VP3 structural protein of foot-and-mouth disease virus inhibits the IFN-β signaling pathway[J]. FASEB J, 2016, 30(5):1757-1766.
[5] LI X Y, WANG J C, LIU J, et al. Engagement of soluble resistance-related calcium binding protein (sorcin) with foot-and-mouth disease virus (FMDV) VP1 inhibits type I interferon response in cells[J]. Vet Microbiol, 2013, 166(1-2):35-46.
[6] AKIRA S, UEMATSU S, TAKEUCHI O. Pathogen recognition and innate immunity[J]. Cell, 2006, 124(4):783-801.
[7] LIAO Z W, WAN Q Y, SU H, et al. Pattern recognition receptors in grass carp Ctenopharyngodon idella:I. Organization and expression analysis of TLRs and RLRs[J]. Dev Comp Immunol, 2017, 76:93-104.
[8] BHATELIA K, SINGH K, SINGH R. TLRs:Linking inflammation and breast cancer[J]. Cell Signal, 2014, 26(11):2350-2357.
[9] KATO H, TAKEUCHI O, SATO S, et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses[J]. Nature, 2006, 441(7089):101-105.
[10] LI W W, ZHU Z X, CAO W J, et al. Esterase D enhances type I interferon signal transduction to suppress foot-and-mouth disease virus replication[J]. Mol Immunol, 2016, 75:112-121.
[11] WU Y B, WU X Q, WU L H, et al. The anticancer functions of RIG-I-like receptors, RIG-I and MDA5, and their applications in cancer therapy[J]. Transl Res, 2017, 190:51-60.
[12] LIN D D, ZHANG M, ZHANG M X, et al. Induction of USP25 by viral infection promotes innate antiviral responses by mediating the stabilization of TRAF3 and TRAF6[J]. Proc Natl Acad Sci U S A, 2015, 112(36):11324-11329.
[13] SHU H B, WANG Y Y. Adding to the STING[J]. Immunity, 2014, 41(6):871-873.
[14] REN C, ZHANG J, YAN W S, et al. RNA-binding protein PCBP2 regulates p73 expression and p73-dependent antioxidant defense[J]. J Biol Chem, 2016, 291(18):9629-9337.
[15] YANATORI I, RICHARDSON D R, TOYOKUNI S, et al. The iron chaperone poly(rC)-binding protein 2 forms a metabolon with the heme oxygenase 1/cytochrome P450 reductase complex for heme catabolism and iron transfer[J]. J Biol Chem, 2017, 292(32):13205-13229.
[16] WAN C G, GONG C, ZHANG H F, et al. β2-adrenergic receptor signaling promotes pancreatic ductal adenocarcinoma (PDAC) progression through facilitating PCBP2-dependent c-myc expression[J]. Cancer Lett, 2016, 373(1):67-76.
[17] BEDARD K M, DAIJOGO S, SEMLER B L. A nucleo-cytoplasmic SR protein functions in viral IRES-mediated translation initiation[J]. EMBO J, 2007, 26(2):459-467.
[18] YOU F P, SUN H, ZHOU X, et al. PCBP2 mediates degradation of the adaptor MAVS via the HECT ubiquitin ligase AIP4[J]. Nat Immunol, 2009, 10(12):1300-1308.
[19] ROBINSON L, KNIGHT-JONES T J D, CHARLESTON B, et al. Global Foot-and-Mouth disease research update and gap analysis:7-pathogenesis and molecular biology[J]. Transbound Emerg Dis, 2016, 63(S1):63-71.
[20] KNOWLES N J, SAMUEL A R. Molecular epidemiology of Foot-and-Mouth disease virus[J]. Virus Res, 2003, 91(1):65-80.
[21] ROBINSON L, KNIGHT-JONES T J D, CHARLESTON B, et al. Global Foot-and-Mouth disease research update and gap analysis:6-immunology[J]. Transbound Emerg Dis, 2016, 63(S1):56-62.
[22] KATOCH A, GEORGE B, IYYAPPAN A, et al. Interplay between PTB and miR-1285 at the p533'UTR modulates the levels of p53 and its isoform Δ40p53α[J]. Nucleic Acids Res, 2017, 45(17):10206-10217.
[23] MAHONY R, BROADBENT L, MAIER-MOORE J S, et al. The RNA binding protein La/SS-B promotes RIG-I-mediated type I and type Ⅲ IFN responses following Sendai viral infection[J]. Sci Rep, 2017, 7:14537.
[24] KIEFT J S, ZHOU K H, GRECH A, et al. Crystal structure of an RNA tertiary domain essential to HCV IRES-mediated translation initiation[J]. Nat Struct Biol, 2002, 9(5):370-374.
[25] EL-HAGE N, LUO G X. Replication of hepatitis C virus RNA occurs in a membrane-bound replication complex containing nonstructural viral proteins and RNA[J]. J Gen Virol, 2003, 84(Pt 10):2761-2769.
[26] CHOI K S, MIZUTANI A, LAI M M C. SYNCRIP, a member of the heterogeneous nuclear ribonucleoprotein family, is involved in mouse hepatitis virus RNA synthesis[J]. J Virol, 2004, 78(23):13153-13162.
[27] CHENG M H K, JANSEN R P. A jack of all trades:the RNA-binding protein vigilin[J]. Wiley Interdiscip Rev RNA, 2017, 8(6):e1448.
[28] JI X J, PARK J W, BAHRAMI-SAMANI E, et al. αCP binding to a cytosine-rich subset of polypyrimidine tracts drives a novel pathway of cassette exon splicing in the mammalian transcriptome[J]. Nucleic Acids Res, 2016, 44(5):2283-2297.
[29] TANG S L, GAO Y L, CHEN X B. MicroRNA-214 targets PCBP2 to suppress the proliferation and growth of glioma cells[J]. Int J Clin Exp Pathol, 2015, 8(10):12571-12576.
[30] GHANEM L R, KROMER A, SILVERMAN I M, et al. The Poly(C) binding protein Pcbp2 and its retrotransposed derivative Pcbp1 are independently essential to mouse development[J]. Mol Cell Biol, 2015, 36(2):304-319.
[31] GAO Y, SUN S Q, GUO H C. Biological function of Foot-and-mouth disease virus non-structural proteins and non-coding elements[J]. Virol J, 2016, 13:107.
[32] JACOBS J L, COYNE C B. Mechanisms of MAVS regulation at the mitochondrial membrane[J]. J Mol Biol, 2013, 425(24):5009-5019. |